Cargando…
Clostridium novyi-NT in cancer therapy
The attenuated anaerobic bacterium Clostridium novyi-NT (C. novyi-NT) is known for its ability to precisely germinate in and eradicate treatment-resistant hypoxic tumors in various experimental animal models and spontaneously occurring canine sarcomas. In this article, we review the therapeutic and...
Autores principales: | Staedtke, Verena, Roberts, Nicholas J., Bai, Ren-Yuan, Zhou, Shibin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6150096/ https://www.ncbi.nlm.nih.gov/pubmed/30258882 http://dx.doi.org/10.1016/j.gendis.2016.01.003 |
Ejemplares similares
-
Clostridium novyi-NT can cause regression of orthotopically implanted glioblastomas in rats
por: Staedtke, Verena, et al.
Publicado: (2015) -
Neutrophil depletion enhanced the Clostridium novyi-NT therapy in mouse and rabbit tumor models
por: Staedtke, Verena, et al.
Publicado: (2021) -
Novel insights into the role of Clostridium novyi-NT related combination bacteriolytic therapy in solid tumors
por: Feng, Xu, et al.
Publicado: (2021) -
Methods and Techniques to Facilitate the Development of Clostridium novyi NT as an Effective, Therapeutic Oncolytic Bacteria
por: Dailey, Kaitlin M., et al.
Publicado: (2021) -
Immune response to C. novyi-NT immunotherapy
por: DeClue, Amy E., et al.
Publicado: (2018)